Evidence map›Paper›PMID 33562660›Full record

ReviewCells2021

The Role of HSPB8, a Component of the Chaperone-Assisted Selective Autophagy Machinery, in Cancer.

Riccardo Cristofani, Margherita Piccolella, Valeria Crippa, Barbara Tedesco, Marina Montagnani Marelli, Angelo Poletti, Roberta M Moretti

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Spectrum of Small Heat Shock Protein B8 (International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Riccardo CristofaniDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Dipartimento di Eccellenza 2018-2022, Università degli Studi di Milano, 20133 Milan, Italy.ORCID 0000-0003-2719-846X
Margherita PiccolellaDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Dipartimento di Eccellenza 2018-2022, Università degli Studi di Milano, 20133 Milan, Italy.ORCID 0000-0002-5130-1116
Valeria CrippaDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Dipartimento di Eccellenza 2018-2022, Università degli Studi di Milano, 20133 Milan, Italy.
Barbara TedescoDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Dipartimento di Eccellenza 2018-2022, Università degli Studi di Milano, 20133 Milan, Italy.
Marina Montagnani MarelliDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Dipartimento di Eccellenza 2018-2022, Università degli Studi di Milano, 20133 Milan, Italy.ORCID 0000-0002-3739-6278
Angelo PolettiDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Dipartimento di Eccellenza 2018-2022, Università degli Studi di Milano, 20133 Milan, Italy.ORCID 0000-0002-8883-0468
Roberta M MorettiDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Dipartimento di Eccellenza 2018-2022, Università degli Studi di Milano, 20133 Milan, Italy.ORCID 0000-0001-6456-5869
University of Milan · IT

Funding

Agenzia Italiana del Farmaco, Ministero della Salute Co_ALSAssociation Française contre les Myopathies 16406EU Joint Programme - Neurodegenerative Disease Research Grant ID: 01ED1601A, CureALSFondazione Cariplo 2014-0686Fondazione Cariplo 2017_0747Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica ALS_GranulopathyFondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica ALS_HSPB8Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica MLOpathyFondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica Target-RANFondazione Regionale per la Ricerca Biomedica (FRRB) (Regione Lombardia) TRANS_ALS, project nr. 2015-0023Fondazione Telethon GGP14039Fondazione Telethon GGP19128Kennedy's Disease Association 2018 grantMinistero della Salute GR-2011-02347198Ministero dell'Istruzione, dell'Università e della Ricerca Fondo per il Finanziamento delle Attività Base di Ricerca (FFABR)Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 2015LFPNMNMinistero dell'Istruzione, dell'Università e della Ricerca PRIN 2017F2A2C5Ministero dell'Istruzione, dell'Università e della Ricerca Progetto Dipartimenti di EccellenzaUniversità degli Studi di Milano Bando SEED 2019: #TDP-43-iPSCUniversità degli Studi di Milano Piano di sviluppo UNIMI - linea B
6 · The paper itself

Abstract

The cellular response to cancer-induced stress is one of the major aspects regulating cancer development and progression. The Heat Shock Protein B8 (HSPB8) is a small chaperone involved in chaperone-assisted selective autophagy (CASA). CASA promotes the selective degradation of proteins to counteract cell stress such as tumor-induced stress. HSPB8 is also involved in (i) the cell division machinery regulating chromosome segregation and cell cycle arrest in the G0/G1 phase and (ii) inflammation regulating dendritic cell maturation and cytokine production. HSPB8 expression and role are tumor-specific, showing a dual and opposite role. Interestingly, HSPB8 may be involved in the acquisition of chemoresistance to drugs. Despite the fact the mechanisms of HSPB8-mediated CASA activation in tumors need further studies, HSPB8 could represent an important factor in cancer induction and progression and it may be a potential target for anticancer treatment in specific types of cancer. In this review, we will discuss the molecular mechanism underlying HSPB8 roles in normal and cancer conditions. The basic mechanisms involved in anti- and pro-tumoral activities of HSPB8 are deeply discussed together with the pathways that modulate HSPB8 expression, in order to outline molecules with a beneficial effect for cancer cell growth, migration, and death.

Indexed as

AutophagyHeat-Shock ProteinsHumansMolecular ChaperonesNeoplasmsHeat-Shock ProteinsHSPB8 protein, humanMolecular ChaperonesautophagycancerCASAchaperonesHSPB8PQC

Identifiers

PMID33562660
PMCPMC7915307
OpenAlexW3126154755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.